Publication | Open Access

Presence of an oligodendroglioma-like component in newly diagnosed glioblastoma identifies a pathogenetically heterogeneous subgroup and lacks prognostic value: central pathology review of the EORTC_26981/NCIC_CE.3 trial

Neuro-oncologyTumoral PathologyTumor HeterogeneityMedicineBrain Tumor BiologyPathologyEortc_26981/ncic_ce.3 TrialNeurologyHigh-grade GliomasOligodendroglioma-like ComponentHeterogeneous SubgroupRadiation OncologyOncologyGliomaGlioblastomaTumor BiologyHealth Sciences